TH1TH2 CD4+T

Yasuo Matsubara1,2, Yasunori Ota3, Tamami Denda3

  • 1Department of Oncology and General Medicine, Institute of Medical Science, IMSUT Hospital, The University of Tokyo, 4-6-1 Shirokanedai, Minato-Ku, Tokyo, 108-8639, Japan. ma-yasu@ims.u-tokyo.ac.jp.

概括

异质造血干细胞移植 (HSCT) 幸存者显示结肠癌风险增加. 在结肠腺瘤中,T细胞功能受损,而不是细胞数量受损,可能会导致这种二次癌症的发展.